Mama's Creations, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Mama's Creations, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | $95.42M | Apr 26, 2023 |
| FY2023 | Jan 31, 2022 | $48.80M | Apr 26, 2023 |
| FY2012 | Jun 30, 2012 | $0 | Oct 1, 2012 |
| FY2012 | Jun 30, 2011 | $0 | Oct 1, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $171.71M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $123.33M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $103.28M | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $93.19M | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $47.08M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $40.76M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $33.75M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $28.47M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $27.54M | Apr 23, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $43.05M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $30.53M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $30.33M | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $19.42M | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $11.85M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $12.74M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $9.98M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $9.89M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $9.26M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $7.22M | May 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $5.29M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $3.71M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $6.56M | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $2.30M | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | ($251.9K) | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $4.07M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $1.53M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $453.5K | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $319.7K | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | ($301.1K) | May 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $7.11M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $4.88M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $8.89M | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $2.82M | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $82.8K | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $3.48M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $2.08M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $1.47M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $1.06M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $456.0K | May 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $288.0K | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $455.0K | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $414.0K | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $135.0K | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $120.7K | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $110.7K | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $114.6K | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $130.9K | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $138.0K | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $153.3K | May 16, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $35.65M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $25.20M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $21.03M | Apr 14, 2026 |
| FY2017 | Jan 31, 2017 | $42.0K | Mar 23, 2017 |
| FY2017 | Jan 31, 2016 | $24.0K | Mar 23, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $11.42M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $5.18M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $11.62M | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $5.51M | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $909.8K | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $3.70M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $1.81M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $1.44M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $1.32M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $357.2K | May 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.65M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $5.10M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $786.0K | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | $593.0K | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | $10.41M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $419.4K | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $268.1K | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $1.03M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $1.47M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $552.9K | May 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $85.70M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $47.06M | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | $45.10M | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | $34.59M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $30.03M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $14.05M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $9.94M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $7.67M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $7.27M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $5.06M | May 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $33.08M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $22.17M | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | $25.52M | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | $22.07M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $21.92M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $5.74M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $9.54M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $8.95M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $9.21M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | $7.74M | May 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $52.62M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $24.90M | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | $19.58M | Apr 14, 2026 |
| FY2026 | Jan 31, 2023 | $12.52M | Apr 14, 2026 |
| FY2025 | Jan 31, 2022 | $8.11M | Apr 8, 2025 |
| FY2023 | Jan 31, 2021 | $8.31M | Apr 26, 2023 |
| FY2022 | Jan 31, 2020 | $402.1K | May 27, 2022 |
| FY2021 | Jan 31, 2019 | ($1.28M) | Apr 21, 2021 |
| FY2020 | Jan 31, 2018 | ($1.93M) | Apr 23, 2020 |
| FY2019 | Jan 31, 2017 | ($2.68M) | Apr 23, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $9.45M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $8.63M | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | $8.63M | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | $8.63M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $8.63M | Apr 26, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $5.45M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $164.0K | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | ($3.55M) | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | ($10.06M) | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | ($12.33M) | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | ($12.08M) | May 27, 2022 |
| FY2021 | Jan 31, 2020 | ($16.14M) | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | ($17.68M) | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | ($18.13M) | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | ($18.36M) | May 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $19.95M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | $7.15M | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | $11.02M | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | $4.38M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $850.6K | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | $3.19M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | $393.7K | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | $609.4K | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | $581.3K | Apr 23, 2019 |
| FY2019 | Jan 31, 2017 | $670.8K | Apr 23, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $5.59M | Apr 14, 2026 |
| FY2020 | Jan 31, 2020 | $4.08M | Apr 23, 2020 |
| FY2019 | Jan 31, 2019 | $5.97M | Apr 23, 2019 |
| FY2018 | Jan 31, 2018 | $5.75M | May 16, 2018 |
| FY2017 | Jan 31, 2017 | $4.88M | Mar 23, 2017 |
| FY2016 | Jan 31, 2016 | $4.40M | Apr 21, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | 0 | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | 0 | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | 0 | May 27, 2022 |
| FY2021 | Jan 31, 2020 | 0 | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | 0 | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | 0 | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | 0 | May 16, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 0 | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | 0 | Apr 14, 2026 |
| FY2026 | Jan 31, 2024 | 0 | Apr 14, 2026 |
| FY2025 | Jan 31, 2023 | 0 | Apr 8, 2025 |
| FY2023 | Jan 31, 2022 | 0 | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | 0 | May 27, 2022 |
| FY2021 | Jan 31, 2020 | 0 | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | 0 | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | 0 | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | 0 | May 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 40.66M | Apr 14, 2026 |
| FY2026 | Jan 31, 2025 | 37.60M | Apr 14, 2026 |
| FY2025 | Jan 31, 2024 | 37.26M | Apr 8, 2025 |
| FY2024 | Jan 31, 2023 | 36.09M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | 35.76M | Apr 26, 2023 |
| FY2022 | Jan 31, 2021 | 35.60M | May 27, 2022 |
| FY2021 | Jan 31, 2020 | 31.99M | Apr 21, 2021 |
| FY2020 | Jan 31, 2019 | 31.87M | Apr 23, 2020 |
| FY2019 | Jan 31, 2018 | 31.75M | Apr 23, 2019 |
| FY2018 | Jan 31, 2017 | 27.81M | May 16, 2018 |